Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background: A variable percentage of patients with systemic mast cell (MC) activation symptoms meet criteria for systemic mastocytosis (SM). We prospectively evaluated the clinical utility of the REMA score versus serum baseline tryptase (sBt) levels for predicting MC clonality and SM in 158 patients with systemic MC activation symptoms in the absence of mastocytosis in the skin (MIS). Methods: World Health Organization criteria for SM were applied in all cases. MC clonality was defined as the presence of KIT-mutated MC or by a clonal HUMARA test. The REMA score consisted of the assignment of positive or negative points as follows: male (+1), female (–1), sBt <15 µg/l (–1) or >25 µg/l (+2), presence (–2) or absence (+1) of pruritus, hives or angioedema and presence (+3) of presyncope or syncope. Efficiency of the REMA score for predicting MC clonality and SM was assessed by receiver operating characteristic (ROC) curve analyses and compared to those obtained by means of sBt levels alone. Results: Molecular studies revealed the presence of clonal MC in 68/80 SM cases and in 11/78 patients who did not meet the criteria for SM. ROC curve analyses confirmed the greater sensitivity and a similar specificity of the REMA score versus sBt levels (84 vs. 59% and 74 vs. 70% for MC clonality and 87 vs. 62% and 73 vs. 71% for SM, respectively). Conclusions: Our results confirm the clinical utility of the REMA score to predict MC clonality and SM in patients suffering from systemic MC activation symptoms without MIS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indirect signs for the presence of an underlying (occult) SM include an elevated baseline serum tryptase level detected well after complete resolution of all symptoms or a D816V KIT mutation in circulating blood leukocytes, blood count abnormalities (e.g., eosinophilia), symptoms suggestive of SM such as unexplained osteoporosis, gastrointestinal symptoms (diarrhea, abdominal cramps, malabsorption”
From Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome (2019) · cites this paper as [60]
In the citing paper
“The most commonly used and validated is the REMA-score (Red Española de Mastocitosis (Spanish Network on Mastocytosis)) [57], which was initially developed for Hymenoptera venom allergy and later extended to other causes of anaphylaxis.”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [57]
In the citing paper
“The Spanish Network on Mastocytosis score (REMAs) is a validated tool based on combined clinical and laboratory criteria to predict underlying MC clonality risk in patients presenting with anaphylaxis without typical mastocytosis skin changes.12,13”
From Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders (2024) · cites this paper as [12]
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1303 · Cited by 2,313
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationGarcia-Montero, A. C. (2006) · Blood · doi:10.1182/blood-2006-04-015545 · Cited by 504
Self-citationMast cell activation syndrome: Proposed diagnostic criteria
Akin, C., Valent, P., & Metcalfe, D. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.035 · Cited by 327
Álvarez-Twose, I., González de Olano, D., Sánchez-Muñoz, L., Matito, A., Esteban-López, M. I., Vega, A., Mateo, M. B., Alonso Díaz de Durana, M. D., de la Hoz, B., del Pozo Gil, M. D., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.019 · Cited by 294
Self-citationEscribano, L., Álvarez-Twose, I., Sánchez-Muñoz, L., Garcia-Montero, A., Núñez, R., Almeida, J., Jara-Acevedo, M., Teodósio, C., García-Cosío, M., Bellas, C., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.003 · Cited by 292
Self-citationEscribano, L., Diaz‐Agustin, B., López, A., Núñez López, R., García‐Montero, A., Almeida, J., Prados, A., Angulo, M., Herrero, S., Orfao, A., et al. (2004) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.10072 · Cited by 147
Self-citationWu, Y., Basir, Z., Kajdacsy-Balla, A., Strawn, E., Macias, V., Montgomery, K., & Guo, S.-W. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04821-5 · Cited by 114
Cited by
Anaphylaxis: A 2023 practice parameter update
Golden, D. B. K., Wang, J., Waserman, S., Akin, C., Campbell, R. L., Ellis, A. K., Greenhawt, M., Lang, D. M., Ledford, D. K., Lieberman, J., et al. (2024) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.09.015 · Cited by 347
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.01.006 · Cited by 225
“Indirect signs for the presence of an underlying (occult) SM include an elevated baseline serum tryptase level detected after complete resolution of all symptoms or a D816V KIT mutation in circulating blood leukocytes, blood cell count abnormalities (eg, eosinophilia), symptoms suggestive of SM such as unexplained ost…”
BackgroundValent, P., Escribano, L., Broesby‐Olsen, S., Hartmann, K., Grattan, C., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, J. N. G., Kristensen, T., et al. (2014) · Allergy · doi:10.1111/all.12436 · Cited by 174
Self-citationHuman mast cell tryptase in biology and medicine
Vitte, J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.04.001 · Cited by 152
Álvarez-Twose, I., Zanotti, R., González-de-Olano, D., Bonadonna, P., Vega, A., Matito, A., Sánchez-Muñoz, L., Morgado, J. M., Perbellini, O., García-Montero, A., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.020 · Cited by 142
Self-citationHymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice
Bilò, M. B., Pravettoni, V., Bignardi, D., Bonadonna, P., Mauro, M., Novembre, E. M., Quercia, O., Cilia, M., Cortellini, G., Costantino, M., et al. (2018) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0310 · Cited by 141
Weiler, C. R., Austen, K. F., Akin, C., Barkoff, M. S., Bernstein, J. A., Bonadonna, P., Butterfield, J. H., Carter, M., Fox, C. C., Maitland, A., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.023 · Cited by 123
Theoharides, T. C., Tsilioni, I., & Ren, H. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1596800 · Cited by 120
Jara-Acevedo, M., Teodosio, C., Sanchez-Muñoz, L., Álvarez-Twose, I., Mayado, A., Caldas, C., Matito, A., Morgado, J. M., Muñoz-González, J. I., Escribano, L., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.72 · Cited by 114
Self-citationPardanani, A. (2013) · Blood · doi:10.1182/blood-2013-01-453183 · Cited by 101
Álvarez-Cuesta, E., Madrigal‐Burgaleta, R., Broyles, A. D., Cuesta‐Herranz, J., Guzman-Melendez, M. A., Maciag, M. C., Phillips, E. J., Trubiano, J. A., Wong, J. T., Ansotegui, I. J., et al. (2022) · World Allergy Organization Journal · doi:10.1016/j.waojou.2022.100640 · Cited by 99
Diagnosis and treatment of Hymenoptera venom allergy
Ruëff, F., Bauer, A., Becker, S., Brehler, R., Brockow, K., Chaker, A. M., Darsow, U. G., Fischer, J., Fuchs, T., Gerstlauer, M., et al. (2023) · Allergologie select · doi:10.5414/alx02430e · Cited by 93
Risk factors and indicators of severe systemic insect sting reactions
Stoevesandt, J., Sturm, G. J., Bonadonna, P., Elberink, J. N. G. O., & Trautmann, A. (2019) · Allergy · doi:10.1111/all.13945 · Cited by 91
In Vitro Diagnosis of Immediate Drug Hypersensitivity During Anesthesia: A Review of the Literature
Ebo, D. G., Faber, M. A., Elst, J., Gasse, A. L. V., Bridts, C. H., Mertens, C. H., Clerck, L. S. D., Hagendorens, M. M., & Sabato, V. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.01.004 · Cited by 88
Jakob, T., Rafei-Shamsabadi, D. A., Spillner, E., & Müller, S. (2017) · Allergo Journal International · doi:10.1007/s40629-017-0014-2 · Cited by 86
Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021
Lange, M., Hartmann, K., Carter, M. C., Siebenhaar, F., Álvarez‐Twöse, I., Torrado, I., Brockow, K., Renke, J., Irga‐Jaworska, N., Plata‐Nazar, K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052586 · Cited by 84
The presence of mast cell clonality in patients with unexplained anaphylaxis
Gülen, T., Hägglund, H., Sander, B., Dahlén, B., & Nilsson, G. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12369 · Cited by 82
Picard, M., Junior, P. F. G.-B., Mezzano, V., & Castells, M. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.001 · Cited by 81
Bilò, M. B., Martini, M., Tontini, C., Corsi, A., & Antonicelli, L. (2020) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.158 · Cited by 79
Key Issues in Hymenoptera Venom Allergy: An Update
Alfaya, T., Soriano-Gomis, V., Mera, T. S., Castro, A. V., Gutiérrez, J. V., Llamazares, A. A., Antolín‐Amérigo, D., González, F. J. C., Domínguez‐Noche, C., Fernández, D. G., et al. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0123 · Cited by 79
Bonadonna, P., Zanotti, R., Pagani, M., Bonifacio, M., Scaffidi, L., Olivieri, E., Franchini, M., Reccardini, F., Costantino, M. T., Roncallo, C., et al. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.11.025 · Cited by 73
Valent, P., Hartmann, K., Schwaab, J., Alvarez-Twose, I., Brockow, K., Bonadonna, P., Hermine, O., Niedoszytko, M., Carter, M. C., Hoermann, G., et al. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.03.007 · Cited by 72
Blank, S., Grosch, J., Ollert, M., & Bilò, M. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579409 · Cited by 68
In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations
Decuyper, I. I., Mangodt, E. A., Gasse, A. L. V., Claesen, K., Uyttebroek, A. P., Faber, M. A., Sabato, V., Bridts, C. H., Mertens, C. H., Hagendorens, M. M., et al. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0176-x · Cited by 67
Klaiber, N., Kumar, S., & Irani, A.-M. A. (2017) · Current Allergy and Asthma Reports · doi:10.1007/s11882-017-0748-4 · Cited by 63
Mast cell activation disorders
Akin, C. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2014.03.007 · Cited by 56
“Based on the findings, a clinical score termed REMA score (REMA is the abbreviation for Spanish Network of Mastocytosis), which takes into account the presence or absence of urticaria, sex, and tryptase levels was devised, and showed a high predictive value in determining the presence of clonal mast cell disease and,…”
Broesby-Olsen, S., Oropeza, A. R., Bindslev-Jensen, C., Vestergaard, H., Møller, M. B., Siebenhaar, F., Kristensen, T., & Mortz, C. G. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.031 · Cited by 54
Spectrum of mast cell activation disorders
Petra, A. I., Panagiotidou, S., Stewart, J. M., Conti, P., & Theoharides, T. C. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.906302 · Cited by 54
Bilò, M. B., Martini, M., Tontini, C., Mohamed, O. E., & Krishna, M. T. (2019) · Clinical & Experimental Allergy · doi:10.1111/cea.13402 · Cited by 53
Anaphylaxis as a clinical manifestation of clonal mast cell disorders
Matito, A., Alvarez-Twose, I., Morgado, J. M., Sánchez-Muñoz, L., Orfao, A., & Escribano, L. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0450-8 · Cited by 51
Self-citationSordi, B., Vanderwert, F., Crupi, F., Gesullo, F., Zanotti, R., Bonadonna, P., Crosera, L., Elena, C., Fiorelli, N., Ferrari, J., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.09.038 · Cited by 51
Clinical aspects of hymenoptera venom allergy and venom immunotherapy
Bilò, M. B., Tontini, C., Martini, M., Corsi, A., Agolini, S., & Antonicelli, L. (2019) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.113 · Cited by 50
Systemic mastocytosis as a risk factor for severe Hymenoptera sting–induced anaphylaxis
Álvarez‐Twöse, I., Bonadonna, P., Matito, A., Zanotti, R., González‐de‐Olano, D., Sánchez‐Muñoz, L., Morgado, J. M., Órfão, A., & Escribano, L. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.10.052 · Cited by 50
Self-citationHaenisch, B., Nöthen, M. M., & Molderings, G. J. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03627.x · Cited by 48
Valent, P. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12318 · Cited by 47
Korošec, P., Sturm, G. J., Lyons, J. J., Marolt, T. P., Svetina, M., Košnik, M., Zidarn, M., Kačar, M., Frelih, N., Lalek, N., et al. (2024) · Allergy · doi:10.1111/all.16084 · Cited by 46
Kopač, P., Čustović, A., Zidarn, M., Šilar, M., Šelb, J., Bajrović, N., Eržen, R., Košnik, M., & Korošec, P. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.04.045 · Cited by 42
Butterfield, J., & Weiler, C. R. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.02.021 · Cited by 41
Idiopathic anaphylaxis yardstick
Carter, M. C., Akin, C., Castells, M., Scott, E. P., & Lieberman, P. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.08.024 · Cited by 41
Nonclonal Mast Cell Activation Syndrome
Hamilton, M. J. (2018) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2018.04.002 · Cited by 40
Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis
Kačar, M., Rijavec, M., Šelb, J., & Korošec, P. (2023) · Clinical & Experimental Allergy · doi:10.1111/cea.14264 · Cited by 37
The Role of Mast Cells in the Induction and Maintenance of Inflammation in Selected Skin Diseases
Woźniak, E., Owczarczyk-Saczonek, A. B., Lange, M., Czarny, J. H., Wygonowska, E., Placek, W. J., & Nedoszytko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087021 · Cited by 38
Adult anaphylaxis: A state-of-the-art review
Rossi, C. M., Lenti, M. V., & Sabatino, A. D. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.03.003 · Cited by 36
Navarro‐Navarro, P., Álvarez‐Twose, I., Pérez‐Pons, A., Henriques, A., Mayado, A., García‐Montero, A. C., Sánchez‐Muñoz, L., González‐López, O., Matito, A., Caldas, C., et al. (2023) · Allergy · doi:10.1111/all.15584 · Cited by 35
Self-citationActualización en mastocitosis. Parte 1: fisiopatología, clínica y diagnóstico
Azaña, J. M., Torrelo, A., & Matito, A. (2015) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2015.09.007 · Cited by 32
Self-citationOmalizumab as Third-Line Therapy for Urticaria During Pregnancy
Ensina, L. F., Cusato-Ensina, A. P., Camelo‐Nunes, I. C., & Solé, D. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0179 · Cited by 32
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin
Fuchs, D., Kilbertus, A., Kofler, K., von Bubnoff, N., Shoumariyeh, K., Zanotti, R., Bonadonna, P., Scaffidi, L., Doubek, M., Elberink, H. O., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.12.022 · Cited by 30
Mast cell-related disorders presenting with Kounis syndrome
González‐de‐Olano, D., Matito, A., Sánchez-López, P., Sánchez‐Muñoz, L., Morgado, J. M., Teodósio, C., Jara‐Acevedo, M., García‐Montero, A. C., Orfao, A., Escribano, L., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.041 · Cited by 30
Self-citationUse of omalizumab for management of idiopathic anaphylaxis
Kaminsky, L. W., Aukstuolis, K., Petroni, D., & Al‐Shaikhly, T. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.06.017 · Cited by 29
Decuyper, I. I., Ebo, D. G., Uyttebroek, A. P., Hagendorens, M. M., Faber, M. A., Bridts, C. H., Clerck, L. S. D., & Sabato, V. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.06.043 · Cited by 29
Insights in Anaphylaxis and Clonal Mast Cell Disorders
González‐de‐Olano, D., & Álvarez‐Twöse, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00792 · Cited by 28
Self-citationMast Cell Clonal Disorders: Classification, Diagnosis and Management
Onnes, M. C., Tanno, L. K., & Elberink, J. N. G. O. (2016) · Current Treatment Options in Allergy · doi:10.1007/s40521-016-0103-3 · Cited by 25
Venom Immunotherapy: an Updated Review
Antolín‐Amérigo, D., Moreno, C., Vega, A., & Álvarez‐Mon, M. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0449-1 · Cited by 25
Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update
Wang, J., Lieberman, J. A., Wallace, D. V., Waserman, S., & Golden, D. B. K. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.06.036 · Cited by 24
Insect sting allergy in adults: key messages for clinicians
Nittner‐Marszalska, M., & Cichocka‐Jarosz, E. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3216 · Cited by 24
Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and Diagnosis
Azaña, J. M., Torrelo, A., & Matito, A. (2015) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2015.11.001 · Cited by 24
Self-citationComponent-resolved diagnosis in hymenoptera allergy
Antolín‐Amérigo, D., Ruiz-León, B., Boni, E., Alfaya, T., Álvarez‐Mon, M., Barbarroja-Escudero, J., González‐de‐Olano, D., Moreno, C., Rodríguez-Rodríguez, M., Sánchez-González, M. J., et al. (2017) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2017.05.003 · Cited by 24
Self-citationZaghmout, T., Maclachlan, L., Bedi, N., & Gülen, T. (2024) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2023.11.041 · Cited by 23
Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders
Beyens, M., Toscano, A., Ebo, D., Gülen, T., & Sabato, V. (2023) · Diagnostics · doi:10.3390/diagnostics13243662 · Cited by 22
Venom Anaphylaxis: Decision Points for a More Aggressive Workup
Bonadonna, P., Korošec, P., Nalin, F., & Golden, D. B. K. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.04.016 · Cited by 22
Risk Factors for Severe Sting Reactions and Side Effects During Venom Immunotherapy
Sturm, G. J., Schadelbauer, E., Marta, G., Bonadonna, P., & Košnik, M. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.08.025 · Cited by 21
Detection of KIT Mutations in Systemic Mastocytosis: How, When, and Why
Cilloni, D., Maffeo, B., Savi, A., Danzero, A. C., Bonuomo, V., & Fava, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010885 · Cited by 21
Recent advances in the understanding and therapeutic management of mastocytosis
Rossignol, J., Polivka, L., Maouche-Chrétien, L., Frenzel, L., Dubreuil, P. C., & Hermine, O. (2019) · F1000Research · doi:10.12688/f1000research.19463.1 · Cited by 21
Rama, T. A., Torrado, I., Henriques, A. F., Sánchez-Muñoz, L., Jara-Acevedo, M., Navarro-Navarro, P., Caldas, C., Mayado, A., Muñoz-González, J., García-Montero, A., et al. (2023) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.11.042 · Cited by 20
Self-citationMast Cell Disorders and Hymenoptera Venom-Triggered Anaphylaxis: Evaluation and Management
Boggs, N. A., Tanasi, I., Hartmann, K., Zanotti, R., & González‐de‐Olano, D. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.08.034 · Cited by 20
Self-citationPediatric Expression of Mast Cell Activation Disorders
Broesby‐Olsen, S., Carter, M. C., Kjær, H. F., Mortz, C. G., Møller, M. B., Kristensen, T. K., Bindslev‐Jensen, C., & Agertoft, L. (2018) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2018.04.009 · Cited by 20
Vázquez‐Revuelta, P., & González‐de‐Olano, D. (2018) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0233 · Cited by 20
Self-citationMastocytosis presenting as insect anaphylaxis: gender differences and natural history
Álvarez‐Twöse, I., & Matito, A. (2019) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000567 · Cited by 20
Self-citationClinical Approach to Mast Cell Activation Syndrome: A Practical Overview
Matito, A., Escribese, M. M., Longo, N., Mayorga, C., Luengo, O., Pérez‐Gordo, M., Matheu, V. M., Labrador‐Horrillo, M., & Seoane-Reula, E. (2021) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0675 · Cited by 20
Self-citationDisease Spectrum of Anaphylaxis Disorders
González de Olano, D., Cain, W. V., Bernstein, J. A., & Akin, C. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.05.012 · Cited by 19
Self-citationIdiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome
Giannetti, M. P., Akin, C., & Castells, M. (2020) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.10.048 · Cited by 19
Safety of ultra‐rush protocols for hymenoptera venom immunotherapy in systemic mastocytosis
Gruzelle, V., Ramassamy, M., Livideanu, C. B., Didier, A. P., Mailhol, C., & Guilleminault, L. (2018) · Allergy · doi:10.1111/all.13557 · Cited by 19
Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review
Sabato, V., Michel, M., Blank, U., Ebo, D. G., & Vitte, J. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000768 · Cited by 19
Extrinsic and Intrinsic Modulators of Anaphylaxis
Carter, M. C., Park, J., Vadas, P., & Worm, M. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.05.015 · Cited by 17
Bovine Amniotic Fluid: A New and Occupational Source of Galactose-α-1,3-Galactose
Orjales, R. N., Martin-Lazaro, J., López-Freire, S., Nieto, A. G., Vega, M. L., & González, F. J. C. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0170 · Cited by 17
Hidden and Rare Food Allergens in Pediatric Age
Tomei, L., Muraro, A. M., Giovannini, M., Barni, S., Liccioli, G., Paladini, E., Sarti, L., Pessina, B., Skypala, I. J., Novembre, E. M., et al. (2023) · Nutrients · doi:10.3390/nu15061386 · Cited by 17
Clonal Mast Cell Activation Syndrome with Anaphylaxis to Sulfites
Cifuentes, L., Ring, J., & Brockow, K. (2013) · International Archives of Allergy and Immunology · doi:10.1159/000348379 · Cited by 17
Insect Sting Anaphylaxis—Or Mastocytosis—Or Something Else?
Golden, D. B. K., & Carter, M. C. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.01.014 · Cited by 16
Diagnosis and Management of Patients With Mast Cell Activation Syndromes: Status 2026
Akin, C., Gülen, T., Castells, M., Elberink, H. O., & Valent, P. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.10.046 · Cited by 15
Navarro‐Navarro, P., González-Tablas, M., Pérez‐Pons, A., Sánchez‐Muñoz, L., Henriques, A., Álvarez‐Twöse, I., Nafria, P., Araco-Sánchez, D., Morales‐Cabeza, C., Caligaris, H., et al. (2025) · Blood · doi:10.1182/blood.2025029507 · Cited by 15
Self-citationSolano-Solares, E., Madrigal‐Burgaleta, R., Carpio-Escalona, L., Bernal-Rubio, L., Berges-Gimeno, M., & Álvarez-Cuesta, E. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0171 · Cited by 15
Hymenoptera Venom Allergy and Anaphylaxis
Bilò, M. B., Martini, M., Danieli, M. G., & Moroncini, G. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220817091039 · Cited by 14
Molecular diagnosis usefulness for idiopathic anaphylaxis
Cardona, V., Guilarte, M., & Labrador‐Horrillo, M. (2020) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000625 · Cited by 14
Elst, J., Puysseleyr, L. P. D., Ebo, D. G., Faber, M. A., Gasse, A. L. V., van der Poorten, M. M., Decuyper, I. I., Bridts, C. H., Mertens, C. H., Houdt, M. V., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835618 · Cited by 14
Mastocytosis and related entities: A practical roadmap
Beyens, M., Elst, J., van der Poorten, M.-L., Van Gasse, A., Toscano, A., Verlinden, A., Vermeulen, K., Maes, M.-B., Oude Elberink, J. N. G. H., Ebo, D., et al. (2023) · Acta Clinica Belgica · doi:10.1080/17843286.2022.2137631 · Cited by 13
Diagnosis of Primary Mast Cell Disorders in Anaphylaxis: Value of KIT D816V in Peripheral Blood
De Puysseleyr, L. P., Ebo, D. G., Elst, J., Faber, M. A., Poorten, M.-L. V. D., Van Gasse, A. L., Bridts, C. H., Mertens, C., Van Houdt, M., Hagendorens, M. M., et al. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.04.062 · Cited by 13
Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases
Prieto, A., Álvarez‐Perea, A., Matito, A., Sánchez‐Muñoz, L., Morgado, J. M., Escribano, L., & Álvarez‐Twöse, I. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2015.01.011 · Cited by 13
Self-citationUnderlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal
Tanasi, I., Crosera, L., Taus, F., Orsolini, G., Adami, G., Olivieri, F., Bernardelli, A., Bonadonna, P., Nalin, F., Sella, S., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117141 · Cited by 12
New Approaches to Chemotherapeutic Drug Allergy: From Drug Challenge to Desensitization
Madrigal‐Burgaleta, R., Banerji, A., Vázquez‐Revuelta, P., & Guyer, A. C. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.02.042 · Cited by 12
Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders
Muñoz‐González, J. I., García‐Montero, A. C., Órfão, A., & Álvarez‐Twöse, I. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.07.014 · Cited by 12
Self-citationMcMurray, J. C., Pacheco, C. S., Schornack, B. J., Sun, X., Brunader, J. A., Scott, A. E., Ariza, J. S., Kou, C.-T. J., Costantino, R. C., Pittman, L. M., et al. (2024) · Blood · doi:10.1182/blood.2023023347 · Cited by 11
New Insights into Clonal Mast Cell Disorders Including Mastocytosis
Volertas, S., Schuler, C. F., IV, & Akin, C. (2018) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2018.04.014 · Cited by 11
How to diagnose Mast Cell Activation Syndrome? Practical considerations
Romantowski, J., Górska, A., Lange, M., Nedoszytko, B., Gruchała‐Niedoszytko, M., & Niedoszytko, M. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15212 · Cited by 11
Valent, P., Arock, M., Akin, C., & Metcalfe, D. D. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.04.041 · Cited by 11
Morales‐Cabeza, C., Prieto, A., Acero, S., Bartolomé-Zavala, B., Morgado, J. M., Matito, A., Sánchez‐Muñoz, L., & Álvarez‐Twöse, I. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.07.002 · Cited by 11
Self-citationHymenoptera venom allergy in children
Giovannini, M., Mori, F., Barni, S., Saretta, F., Arasi, S., Castagnoli, R., Liotti, L., Mastrorilli, C., Pecoraro, L., Caminiti, L., et al. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01731-9 · Cited by 10
Safety and Adherence to Venom Immunotherapy During COVID-19 Pandemic
Bilò, M. B., Braschi, M. C., Piga, M. A., Antonicelli, L., & Martini, M. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.11.030 · Cited by 10
Mast Cell Activation Syndromes
Bonamichi-Santos, R., & Castells, M. (2016) · Current Treatment Options in Allergy · doi:10.1007/s40521-016-0100-6 · Cited by 10
Acute Localized Exanthematous Pustulosis Due to Bemiparin
Torrijos, E. G., la Calle, M. P. C.-D., Díaz, Y. M., Lozano, L. M., Ortega, A. M. E., Bonilla, P. G., Alfaya, T., & Rodriguez, R. G. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0181 · Cited by 10
Chatain, C., Sedillot, N., Thomas, M., Pernollet, M., Bocquet, A., Boccon‐Gibod, I., Bouillet, L., & Leccia, M. ‐. (2021) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.08.005 · Cited by 10
Metadata
- Authors
- Alvarez-Twose, I., González-de-Olano, D., Sánchez-Muñoz, L., Matito, A., Jara-Acevedo, M., Teodosio, C., García-Montero, A., Morgado, J. M., Orfao, A., & Escribano, L.
- Affiliations
- Hospital Virgen del Valle (ES)
- Universidad de Salamanca (ES)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2011-10-28
- Volume
- 157
- Issue
- 3
- Pages
- 275-280
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2033518553
- Cited by
- 184
- References
- 15
- Citations by year
- 2026: 3 · 2025: 19 · 2024: 16 · 2023: 13 · 2022: 18 · 2021: 15 · 2020: 14 · 2019: 16 · 2018: 11 · 2017: 23 · 2016: 6 · 2015: 9 · 2014: 11 · 2013: 4 · 2012: 5
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
- Keywords
- systemic mastocytosis, serum tryptase, KIT mutations, pruritus, angioedema, diagnostic prediction
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Decision Support Techniques, Female, Humans, Male, Mast Cells, Middle Aged, Prospective Studies, Pruritus, ROC Curve, Sex Factors, Syncope, Urticaria, Biomarkers, Proto-Oncogene Proteins c-kit, Mastocytosis, Systemic, Tryptases, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.